Home   >  
Protease/Metabolic Enzyme
  >  
Proteasome

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Proteasome

Chemical Structure Cat. No. Product Name CAS No.
Lactacystin Chemical Structure
BCP13243 Lactacystin 133343-34-7
Lactacystin is a specific and an irreversible inhibitor of proteasome with IC50 value of 4.8 μM.
(R)-MG-132 Chemical Structure
BCP28290 (R)-MG-132 1211877-36-9
MG132 is a potent 20S proteasome inhibitor (IC50 = 0.22 nM). Exhibits cytostatic and cytotoxic effects in tumor cells in vitro.
PI-1840 Chemical Structure
BCP28597 PI-1840 1401223-22-0
PI-1840 is a potent and selective inhibitor for chymotrypsin-like (CT-L) (IC50 value = 27 ± 0.14 nM) over trypsin-like and peptidylglutamyl peptide hydrolyzing (IC50 values >100 μM) activities of the proteasome.
Ixazomib citrate Chemical Structure
BCP16600 Ixazomib citrate 1239908-20-3
MLN2238 rapidly hydrolyzes to MLN2238, which is a selective, orally bioavailable, second-generation proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 value of 3.4 nM (Ki of 0.93 nM), and also inhibits the caspase-like (β1) and trypsin-like (β2) proteolytic sites with IC50 of 31 and 3500 nM, respectively.
Cysteine Protease inhibitor Chemical Structure
BCP11075 Cysteine Protease inhibitor 921625-62-9
Cysteine Protease inhibitor is a inhibitor of cysteine protease.
Gabexate mesylate Chemical Structure
BCP13557 Gabexate mesylate 56974-61-9
Gabexate Mesylate is a Factor X inhibitor.
VR23 Chemical Structure
BCP16034 VR23 1624602-30-7
VR23 is a small molecule that potently inhibited the activities of trypsin-like proteasomes
PD 150606 Chemical Structure
BCP17762 PD 150606 179528-45-1
PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor.
ONX-0914 Chemical Structure
BCP07652 ONX-0914 960374-59-8
ONX 0914 is an immunoproteasome inhibitor
Oprozomib Chemical Structure
BCP07603 Oprozomib 935888-69-0
ONX-0912 (as known as oprozomib), is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells.
123下一页共 21 条记录 1 / 3 页 
0086-13720134139